Kawashima Y, Hanioka N, Kozuka H
J Pharmacobiodyn. 1984 May;7(5):286-93. doi: 10.1248/bpb1978.7.286.
The potency of seven phenoxyacetic acid derivatives to induce microsomal stearoyl-CoA desaturation activity in rat liver was compared with that of 2-(4-chlorophenoxy)-2-methyl-propionic acid (clofibric acid). These compounds were given to rats with diet. Of seven phenoxyacetic acid derivatives tested, both 2-(4-chlorophenoxy)-propionic acid and 2-(2-chlorophenoxy)-2-methyl-propionic acid increased considerably the desaturation activity as was observed with clofibric acid. Moreover, 2,4,5-trichlorophenoxyacetic acid (2,4,5-T) also increased the desaturation activity, although the inducing effect on desaturation activity was very weak compared to that of clofibric acid. These three compounds increased activity of terminal desaturase without accompanying marked changes in reduced nicotinamide adenine dinucleotide (NADH)-cytochrome b5 reductase activity and cytochrome b5 content as was the case with clofibric acid. The other four phenoxyacetic acid derivatives, 2-(phenoxy)-propionic acid, 4-chlorophenoxyacetic acid, 2-chlorophenoxyacetic acid and 2, 4-dichlorophenoxyacetic acid (2,4-D) changed scarcely the desaturation activity. These compounds had no influence on NADH-cytochrome b5 reductase activity, cytochrome b5 content and terminal desaturase activity. Correlating with the changes in the desaturation activity, concentration of octadecenoic acid was increased in hepatic microsomes, whole liver and serum. Treatment with clofibric acid did not change the concentration of octadecenoic acid in brain, lung, heart, spleen, testis and adipose tissue.
将七种苯氧乙酸衍生物诱导大鼠肝脏微粒体硬脂酰辅酶A去饱和活性的能力与2-(4-氯苯氧基)-2-甲基丙酸(氯贝酸)进行了比较。这些化合物通过饮食给予大鼠。在所测试的七种苯氧乙酸衍生物中,2-(4-氯苯氧基)丙酸和2-(2-氯苯氧基)-2-甲基丙酸都能显著提高去饱和活性,这与氯贝酸的情况相同。此外,2,4,5-三氯苯氧乙酸(2,4,5-T)也能提高去饱和活性,尽管与氯贝酸相比,其对去饱和活性的诱导作用非常弱。这三种化合物增加了末端去饱和酶的活性,且烟酰胺腺嘌呤二核苷酸(NADH)-细胞色素b5还原酶活性和细胞色素b5含量没有明显变化,氯贝酸的情况也是如此。其他四种苯氧乙酸衍生物,2-(苯氧基)丙酸、4-氯苯氧乙酸、2-氯苯氧乙酸和2,4-二氯苯氧乙酸(2,4-D)几乎没有改变去饱和活性。这些化合物对NADH-细胞色素b5还原酶活性、细胞色素b5含量和末端去饱和酶活性没有影响。与去饱和活性的变化相关,肝脏微粒体、全肝和血清中的十八碳烯酸浓度升高。用氯贝酸处理不会改变脑、肺、心脏、脾脏、睾丸和脂肪组织中十八碳烯酸的浓度。